Jason Cummings

Administrative Professional Microbiology, Immunology, and Pathology

D120 Ric

970-492-4335

About Jason

Mr. Cummings is a Research Associate IV and the Laboratory Manager for Dr. Slayden. He joined the Slayden lab in 2009 with a background in M. tuberculosis vaccine and drug testing in animals. In addition to M. tuberculosis, Mr. Cummings works with Tier 1 select agents (B. pseudomallei, B. mallei, F. tularensis, Y. pestis, and B. anthracis) to determine novel drug efficacy in vitro and in vivo and use next generation sequencing as a tool to better understand host/pathogen interactions in the context of treatment. Mr. Cummings is also tasked with managing ongoing NIH IDIQ and private company contracts. His lab manager responsibilities include maintaining regulatory compliance, personnel training, communication with outside vendors, and budgeting/ordering.

Education

BSc, University of Wyoming, 2003

                

stdClass Object ( [GetMemberByIdResult] => stdClass Object ( [AddressPrivacy] => 1 [BusinessAddress1] => [BusinessAddress2] => [BusinessCity] => [BusinessPostalCode] => [BusinessState] => [CSUId] => 0 [DepartmentGroup] => CVMBS Microbiology, Immunology & Pathology Dept [DirectoryPrivacy] => [EName] => jec [EmailAddress] => J.Cummings@colostate.edu [EmailPrivacy] => [EmployeeCategory] => Staff [EmployeeTitle] => Administrative Professional [EmployeeType] => Administrative Professional [FirstName] => Jason [GraduationYear] => [HasMemberCV] => [Id] => 3498 [InternalTitle] => Administrative Professional [LastName] => Cummings [MemberContacts] => stdClass Object ( [MemberContactResponse] => stdClass Object ( [ContactTypeDescription] => Office [Id] => 3353 [IsPrimary] => [PhoneNumber] => 970-492-4335 ) ) [MemberDirectoryProfile] => stdClass Object ( [Id] => 1003 [ProfileMetaData] => [ProfileText] => Mr. Cummings is a Research Associate IV and the Laboratory Manager for Dr. Slayden. He joined the Slayden lab in 2009 with a background in M. tuberculosis vaccine and drug testing in animals. In addition to M. tuberculosis, Mr. Cummings works with Tier 1 select agents (B. pseudomallei, B. mallei, F. tularensis, Y. pestis, and B. anthracis) to determine novel drug efficacy in vitro and in vivo and use next generation sequencing as a tool to better understand host/pathogen interactions in the context of treatment. Mr. Cummings is also tasked with managing ongoing NIH IDIQ and private company contracts. His lab manager responsibilities include maintaining regulatory compliance, personnel training, communication with outside vendors, and budgeting/ordering. ) [MiddleName] => E [NamePrivacy] => [OfficeBldgName] => Ric [OfficeRoomName] => D120 [OtherName] => Jason [PhonePrivacy] => 1 [StudentLevel] => [Website] => ) )